Breaking The Hair-Loss Barrier: Pattern-Wise Efficacy Of Verilich Serum

    Vimala Manne
    Studysummary This prospective observational study evaluated the use of Verilich serum for hair loss and found that 71.4% of chronic telogen effluvium patients saw significant improvement in hair shedding within 2 months, with no adverse events reported.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on avensonline.org →
    Discuss this study in the Community →